CLINUVEL Pharmaceuticals
Annual Report 2023
Contents
Introduction
Key Achievements
Financial Highlights
Letter from the Chair
Vision, Mission and Values
CLINUVEL’s ESG Practices
Letter from the Managing Director
Operating and Financial Review
1. Distribution of SCENESSE
®
2. Pharmaceutical Product Development
and Clinical Programs
3. PhotoCosmetic Products
4. Financial Review
Plans 2024 and Beyond
Annual Results Appendix 4E - Financial Year Ending 30 June 2023
Shareholder Information
Market Performance
Glossary
Download the PDF of the Annual Report
Previous
Next
Menu
Contents
Introduction
Key Achievements
Financial Highlights
Letter from the Chair
Vision, Mission and Values
CLINUVEL’s ESG Practices
Letter from the Managing Director
Operating and Financial Review
1. Distribution of SCENESSE
®
2. Pharmaceutical Product Development
and Clinical Programs
3. PhotoCosmetic Products
4. Financial Review
Plans 2024 and Beyond
Annual Results Appendix 4E - Financial Year Ending 30 June 2023
Shareholder Information
Market Performance
Glossary
Download the PDF of the Annual Report
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2016
Annual Report 2015
Previous Annual Reports
Download the PDF of the Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2016
Annual Report 2015